Concepedia

David W. Markby

DW

Statistics

Publications

12

Citations

686

H-Index

12

Active since

1986

Affiliations

University of California, Berkeley(Current)

Exelixis (United States)

Memorial Sloan Kettering Cancer Center

University of California, San Francisco

David W. Markby is an author at University of California, Berkeley specializing in medicine, natural sciences, and biochemistry.

Top concepts

Publications per year

1986–2020

12

Publications

12

Separate GTP Binding and GTPase Activating Domains of a Gα Subunit

David W. Markby, René Onrust, Henry R. Bourne · Science · 1993 · 177 citations

Discovery of XL413, a potent and selective CDC7 inhibitor

Elena S. Koltun, Amy Lew Tsuhako, David S. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 90 citations · Full text

, , +5

Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma

Thomas Powles, Robert J. Motzer, Bernard Escudier et al. · British Journal of Cancer · 2018 · 82 citations · Full text

Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma

Robin Kate Kelley, Tim Meyer, Lorenza Rimassa et al. · Clinical Cancer Research · 2020 · 82 citations · Full text

Cooperative binding of the bisubstrate analog N-(phosphonacetyl)-L-aspartate to aspartate transcarbamoylase and the heterotropic effects of ATP and CTP

James Newell, David W. Markby, H. K. Schachman · Journal of Biological Chemistry · 1989 · 45 citations · Full text

1–5 of 12